Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for quarter ended 31st March 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech Ltd has submitted a routine compliance certificate to BSE under SEBI Regulation 74(5) for the quarter ended 31st March 2025. The certificate was issued by RCMC Share Registry Private Limited, the company's Registrar and Share Transfer Agent. It confirms that share certificates received for dematerialisation during the quarter were properly verified, listed on the stock exchanges, and that the original certificates were cancelled and the depository's name was entered in the company's register of members within 15 days. This is a standard quarterly filing required from all listed companies and involves no business or financial decision.
This is a routine regulatory compliance filing with no material impact on the company's operations, financials, or shareholders. Investors should not expect any change in stock price or business outlook from this disclosure.